je.st
news
Tag: treatment
GE's LEAPmbr* Treatment Technology Enables Wastewater Reuse For Drought-Stricken Abilene, Texas
2015-06-05 07:27:16| plantautomation News Articles
With chronic droughts and population growth reducing reservoir levels to 30 percent capacity in the West Texas city of Abilene, the city recently completed the installation of GE’s LEAPmbr* advanced wastewater treatment system as part of major upgrades to the Hamby Wastewater Treatment Plant (WWTP). Despite heavy rainfall that has eased conditions in recent weeks, civic leaders are continuing their efforts to prepare for water scarcity issues in the future
Tags: technology
treatment
texas
enables
GE's LEAPmbr* Treatment Technology Enables Wastewater Reuse For Drought-Stricken Abilene, Texas
2015-06-05 07:27:16| pollutiononline Home Page
With chronic droughts and population growth reducing reservoir levels to 30 percent capacity in the West Texas city of Abilene, the city recently completed the installation of GE’s LEAPmbr* advanced wastewater treatment system as part of major upgrades to the Hamby Wastewater Treatment Plant (WWTP)
Tags: technology
treatment
texas
enables
Alnylam Receives Orphan Drug Designation From The United States Food & Drug Administration For Revusiran, An Investigational RNAi Therapeutic For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
2015-06-03 06:41:56| drugdiscoveryonline Home Page
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced recently that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to revusiran, an investigational RNAi therapeutic, for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis)
Tags: united
states
united states
food
Pfizer's RAPAMUNE (sirolimus) Becomes First FDA-Approved Treatment For Lymphangioleiomyomatosis (LAM), A Rare Progressive Lung Disease
2015-06-03 06:19:12| drugdiscoveryonline Home Page
Pfizer Inc. announced recently that the U.S. Food and Drug Administration (FDA) has approved RAPAMUNE (sirolimus) for the treatment of lymphangioleiomyomatosis (LAM), a rare, progressive disease that affects the lungs, kidneys and the lymphatic system
Tags: treatment
disease
rare
progressive
Humanetics Corporation Granted FDA Clearance To Proceed With Cancer Treatment Study
2015-06-03 05:59:54| drugdiscoveryonline Home Page
Minneapolis-based Humanetics Corporation (Humanetics) announced recently that its Investigational New Drug application for the proprietary compound BIO 300 has cleared U.S
Tags: study
corporation
treatment
cancer
Sites : [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] next »